SCHEMBL30197644

SCHEMBL30197644

NN=C(O)NN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17011955 0.70
SCHEMBL333368 0.67
Hydrochloric Acid SCHEMBL9509466 0.64
SCHEMBL2666532 0.64
SCHEMBL219636 0.64
Hydrochloric Acid SCHEMBL4901904 0.62
Hydrochloric Acid SCHEMBL29043673 0.62
SCHEMBL5924353 0.62
SCHEMBL5924356 0.62
Bromide SCHEMBL11604987 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174965-A1 METHODS AND PRODUCTS UNIV BIRMINGHAM (GB) 2023-06-08 US claimed
EP-4136223-A2 METHODS AND PRODUCTS The University Of Birmingham (GB) 2023-02-22 EP claimed
WO-2025224102-A1 HDAC6 PROTACS AND THEIR USE IN THE TREATMENT OF CANCER, NEURODEGENERATIVE DISEASES, INFLAMMATION AND METABOLIC DISORDERS THE ROYAL COLLEGE OF SURGEONS IN IRELAND (IE) 2025-10-30 WO disclosed
US-20230174965-A1 METHODS AND PRODUCTS UNIV BIRMINGHAM (GB) 2023-06-08 US disclosed
EP-4136223-A2 METHODS AND PRODUCTS The University Of Birmingham (GB) 2023-02-22 EP disclosed